Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 18, 2025 • 9:31 PM ET

Date/Time Source News Release
06/17/2025 08:00 AM EDT Business Wire Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS
05/29/2025 04:05 PM EDT Business Wire Allurion to Present at Jefferies Global Healthcare Conference
05/27/2025 04:05 PM EDT Business Wire Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program
05/14/2025 08:00 AM EDT Business Wire Allurion Reports First Quarter 2025 Financial Results and Provides Business Update
05/13/2025 04:05 PM EDT Business Wire Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss
05/05/2025 04:05 PM EDT Business Wire Allurion to Report First Quarter 2025 Financial Results on May 14, 2025
04/03/2025 04:30 PM EDT Business Wire Allurion Announces Postponement of Special Meeting of Stockholders
03/26/2025 08:00 AM EDT Business Wire Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
03/20/2025 04:05 PM EDT Business Wire Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence
03/12/2025 04:05 PM EDT Business Wire Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025
Page

Additional News

As of June 18, 2025 • 9:31 PM ET

Date/Time Source News Release
05/28/2025 01:30 PM EDT PRISM News PRISM Mid-Day Movers: Weight Loss Innovation and Warrant Cancellation Drive Market Action
05/22/2025 09:36 AM EDT Zacks Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies
05/21/2025 11:37 AM EDT Zacks 4 Medical Product Stocks to Watch From a Challenging Industry
05/19/2025 08:14 AM EDT Stock Traders Daily Trend Tracker for (ALUR)
05/14/2025 04:32 PM EDT PRISM News Allurion Narrows Losses and Advances Toward FDA Submission in Q1 2025; Stock Surges 32%
05/14/2025 02:45 PM EDT SeekingAlpha Allurion outlines path to FDA submission and expects revenue ramp as B2B2C strategy expands in 2025
05/14/2025 02:44 PM EDT SeekingAlpha Allurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript
05/14/2025 10:25 AM EDT Zacks Allurion Technologies, Inc. (ALUR) Q1 Earnings Beat Estimates
05/14/2025 08:55 AM EDT SeekingAlpha Allurion Technologies GAAP EPS of $0.20 beats by $1.61, revenue of $5.6M beats by $0.1M
05/14/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, May 14th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.